Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
9.28
-1.07 (-10.34%)
At close: Feb 21, 2025, 4:00 PM
9.27
-0.01 (-0.11%)
After-hours: Feb 21, 2025, 7:59 PM EST
Recursion Pharmaceuticals Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Recursion Pharmaceuticals stock have an average target of 8.75, with a low estimate of 6.00 and a high estimate of 11. The average target predicts a decrease of -5.71% from the current stock price of 9.28.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Recursion Pharmaceuticals stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Hold | 4 | 4 | 3 | 3 | 3 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 6 | 6 | 5 | 5 | 5 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Needham | Needham | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +18.53% | Feb 6, 2025 |
Keybanc | Keybanc | Buy Maintains $12 → $10 | Buy | Maintains | $12 → $10 | +7.76% | Jan 8, 2025 |
Needham | Needham | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +18.53% | Dec 11, 2024 |
Needham | Needham | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +18.53% | Nov 20, 2024 |
Needham | Needham | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +18.53% | Nov 7, 2024 |
Financial Forecast
Revenue This Year
72.16M
from 44.58M
Increased by 61.89%
Revenue Next Year
94.41M
from 72.16M
Increased by 30.83%
EPS This Year
-1.62
from -1.58
EPS Next Year
-1.74
from -1.62
Revenue Forecast
Revenue | 2024 | 2025 | 2026 |
---|---|---|---|
High | 99.0M | 183.8M | 218.4M |
Avg | 72.2M | 94.4M | 126.3M |
Low | 44.1M | 45.1M | 73.6M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | 122.1% | 154.6% | 131.3% |
Avg | 61.9% | 30.8% | 33.8% |
Low | -1.1% | -37.5% | -22.0% |
EPS Forecast
EPS | 2024 | 2025 | 2026 |
---|---|---|---|
High | -1.54 | -1.40 | -1.12 |
Avg | -1.62 | -1.74 | -1.46 |
Low | -1.86 | -2.84 | -1.76 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.